All Articles

The neurotech pioneer reports strong sales for its spinal cord injury therapy, secures key FDA approvals, and plans for major US stock market entry.

A new, highly selective oral drug for the most common form of dwarfism has been cleared for U.S. trials, offering hope for a more convenient treatment.

In a world of fragile connections, Tata Communications' new AI-powered platform promises to automatically fix network disruptions in seconds. Here's how.

A startling new study reveals a sharp rise in diagnosed anxiety, highlighting a growing public health crisis and an urgent need for treatment innovation.

NXP's Rafael Sotomayor will detail the future of AI in the real world, from autonomous cars to robotics, at Taipei's premier global tech event.

A new report reveals a crisis for older adults on social media, with billions lost to scams and a growing demand for platforms to be held accountable.

Toshiba begins sampling massive 30-34TB hard drives, using advanced tech to help hyperscale data centers cope with the explosive growth of AI and cloud data.

A shocking new installation reveals a dangerous blind spot: your car isn't protecting you from the sun's harmful rays. Here's what you need to know.

PropTech startup Proho secures $1M to scale its AI-powered platform, offering Indian homeowners a guaranteed sale and tackling deep-seated market friction.

As AI agents begin to spend money, UQPAY launches FlashCard, a new payment system designed to provide security and control for autonomous transactions.

A major new machine tool exhibition is coming to Jakarta, aiming to connect global suppliers with Indonesia's booming, import-reliant manufacturing sector.

MBK Rental Living's new Las Brisas community offers resort-style amenities, but its launch highlights the complex housing pressures on California's Central Coast.

The digital lender's record revenue and new blockchain platform aim to unlock trillions in illiquid home equity, charting a bold path to profitability.

The diagnostics firm posts strong thyroid growth after a strategic shift, but a one-time tax adjustment inflates its impressive 2025 bottom line.

After a successful shift to a royalty model, the firm reports stronger financials and confirms it is weighing a merger or acquisition.

The robotics firm completed crucial benchtop tests for its novel single-port system, a major step toward clinical use and challenging market leaders.

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

With founding member Crystal Heter as CEO and a Blackstone exec as Chair, Tallgrass signals a new era focused on disciplined growth and energy transition.

NASDAQ-listed Bio Green Med Solution abandons its biopharma roots for fire safety, slashing losses but facing new questions about its long-term survival.

A new bipartisan bill introduced at the TMCF Fly-In aims to overhaul federal research funding access for HBCUs, addressing a stark inequity in STEM.